High Tower Advisors, LLC Verastem, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.06 - $2.1 $12,204 - $24,179	-11,514 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$2.05 - $3.2 $5,125 - $8,000	-2,500 Reduced 17.84%	11,514 $23,000
Q2 2021 Aug 06, 2021	SELL	$2.57 - $4.85 $24,415 - $46,075	-9,500 Reduced 40.4%	14,014 $57,000
Q1 2021 May 10, 2021	BUY	$1.9 - $2.82 $44,676 - $66,309	23,514 New	23,514 $57,000
Q4 2020 Feb 10, 2021	SELL	$1.15 - $2.4 $16,392 - $34,209	-14,254 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$1.69 - $4.2 $24,089 - $59,866	14,254 New	14,254 $24,000
Q4 2017 Feb 14, 2018	SELL	$2.99 - $4.85 $40,885 - $66,318	-13,674 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $11,016 - $19,800	3,660 Added 36.55%	13,674 $64,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,014	10,014 $21,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.